Digitisation | September 03, 2021
Indigenous technology will help reduce dependence on imports: Dr Singh
Union Minister addresses the 13th CII Global MedTech Summit on the sunrise medical devices sector in India
Union Minister addresses the 13th CII Global MedTech Summit on the sunrise medical devices sector in India
It is estimated that over 11,000 children across Europe, Middle East, and Africa are affected by achondroplasia and could be eligible for treatment with Voxzogo
This facility will integrate with existing Max hospitals and create a 2,300-bed contiguous medical hub spread over 23 acres. The first phase is to be ready by 2024
First and only therapy approved by the FDA for the treatment of pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis
XELJANZ is the first and only Janus kinase (JAK) inhibitor approved in Europe for the treatment of polyarticular JIA and juvenile PsA and has received regulatory approval in four indications in the European Union, the most of any JAK inhibitor
The financing secures funds to advance the clinical development of EpiEndo’s lead compound EP395, which entered phase I clinical trials in April, through Phase IIa, targeting COPD as a primary indication
This therapy may provide the first potential oral treatment for COVID-19, recognizing the global emergency of new SARS-CoV-2 variants
The approval is based on a multi-centre, single-arm, open-label pivotal clinical trial
In the agreement, Marcor, an Azelis Americas company, will distribute the SPI Pharma product lines in the United States, and Azelis Canada Pharma Division will be responsible for the Canadian marketplace
It works as an adjunct to standard care based on robust clinical trials
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
